anticarcinogenic agents

Preferred Label : anticarcinogenic agents;

MeSH definition : Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved.;

MeSH synonym : agents, anti-carcinogenic; anti carcinogenic agents; anti-carcinogenic drugs; anticarcinogenic drugs; drugs, anticarcinogenic; anti carcinogenic drugs; drugs, anti-carcinogenic; anticarcinogens; anti-carcinogenic agents; agents, anticarcinogenic;

Wikipedia automatic translation : Antimutagen;

Related MeSH term : anticarcinogenic effect; Effect, Anticarcinogenic; Anti-Carcinogenic Effects; Anti Carcinogenic Effects; Effects, Anti-Carcinogenic; Anticarcinogenic Effects; Effects, Anticarcinogenic; Anti-Carcinogenic Effect; Anti Carcinogenic Effect; Effect, Anti-Carcinogenic;

MeSH annotation : do not confuse with ANTINEOPLASTIC AGENTS which treat or affect cancer already developed while ANTICARCINOGENIC AGENTS prevent or reduce the development of cancer; note entry term ANTI-CARCINOGENIC EFFECT: use only for the anti-carcinogenic effect of a chemical substance;

Wikipedia link : https://en.wikipedia.org/wiki/Antimutagen;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D016588;

UMLS CUI

C0085169;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Indexing information
- (2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid [MeSH Supplementary Concept]
- BDMC-A [MeSH Supplementary Concept]
- LQM706 [MeSH Supplementary Concept]
- LQM717 [MeSH Supplementary Concept]
- Limonene [MeSH Descriptor]
- adonirubin [MeSH Supplementary Concept]
- gymnasterkoreayne B [MeSH Supplementary Concept]
- sarcophine-diol [MeSH Supplementary Concept]
- vitexin-2-O-rhamnoside [MeSH Supplementary Concept]
- vitexin-2-O-xyloside [MeSH Supplementary Concept]
Ne pas confondre avec
- antibiotics, antineoplastic [MeSH Descriptor]
- antimetabolites, antineoplastic [MeSH Descriptor]
- antineoplastic agents [MeSH Descriptor]
- antineoplastic agents, alkylating [MeSH Descriptor]
- antineoplastic agents, hormonal [MeSH Descriptor]
- antineoplastic agents, phytogenic [MeSH Descriptor]
- antineoplastic combined chemotherapy protocols [MeSH Descriptor]
Record concept(s)
- anticarcinogenic agents [MeSH concept]
- anticarcinogenic effect [MeSH concept]
See also
- antimutagenic agents [MeSH Descriptor]
- antineoplastic agents [MeSH Descriptor]
- carcinogens [MeSH Descriptor]
- chemoprevention [MeSH Descriptor]
- neoplasms [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1,4-phenylenebis(methylene)selenocyanate [MeSH Supplementary Concept]
- 2-hydroxyestrone [MeSH Supplementary Concept]
- 3,3'-diindolylmethane [MeSH Supplementary Concept]
- Lycopene [MeSH Descriptor]
- MSH, 4-Nle-7-Phe-alpha- [MeSH Supplementary Concept]
- Resveratrol [MeSH Descriptor]
- allyl sulfide [MeSH Supplementary Concept]
- biochanin A [MeSH Supplementary Concept]
- bombesin (6-14), Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)- [MeSH Supplementary Concept]
- cholesteryl sulfate [MeSH Supplementary Concept]
- diallyl disulfide [MeSH Supplementary Concept]
- ecabet [MeSH Supplementary Concept]
- epigallocatechin gallate [MeSH Supplementary Concept]
- fenretinide [MeSH Descriptor]
- genistein [MeSH Descriptor]
- indole-3-carbinol [MeSH Supplementary Concept]
- irsogladine [MeSH Supplementary Concept]
- labruscol [MeSH Supplementary Concept]
- maxacalcitol [MeSH Supplementary Concept]
- oltipraz [MeSH Supplementary Concept]
- perilla seed oil [MeSH Supplementary Concept]
- phenethyl isothiocyanate [MeSH Supplementary Concept]
- protocatechuic acid [MeSH Supplementary Concept]
- retinol acetate [MeSH Supplementary Concept]
- retinol palmitate [MeSH Supplementary Concept]
- schizandrol B [MeSH Supplementary Concept]
- selenomethylselenocysteine [MeSH Supplementary Concept]
- squalamine [MeSH Supplementary Concept]
- sulforaphane [MeSH Supplementary Concept]
- sulindac sulfone [MeSH Supplementary Concept]
- trans-sodium crocetinate [MeSH Supplementary Concept]
Validated automatic mappings to NTBT
- Chemopreventive [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients